Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-582-5p


Loading... Please wait, this might take a few seconds...



Filters
Interactions: 643, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
FOXO1 hsa-miR-582-5p low: 3 high: 0 1 1 1 0.899
Low-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Yanhua Liu et al. 2013 WB qP Peripheral Blood THP1 N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot POSITIVE INDIRECT TarBase 7.0
UNKNOWN qPCR POSITIVE INDIRECT TarBase 7.0
Yanhua Liu et al. 2013 RP Peripheral Blood THP1 HEK293T N/A
Location Method Result Regulation Validation Type Source
chr13:40557376-40557402 Luciferase Reporter Assay POSITIVE DIRECT TarBase 7.0
CASP3 hsa-miR-582-5p low: 2 high: 0 1 2 2 -
Low-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Floyd DH. et al. 2014 RP Nervous Glioblastoma A172 N/A
Location Method Result Regulation Validation Type Source
chr4:184628876-184628898 Luciferase Reporter Assay POSITIVE DIRECT TarBase 8.0
Floyd DH. et al. 2014 RP Nervous Glioblastoma U373 N/A
Location Method Result Regulation Validation Type Source
chr4:184628876-184628898 Luciferase Reporter Assay POSITIVE DIRECT TarBase 8.0
Other Databases
Publication Methods Tissue Cell line Tested cell line Exp. condition
Floyd DH. et al. 2014 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
CASP9 hsa-miR-582-5p low: 2 high: 0 1 1 1 -
Low-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Floyd DH. et al. 2014 RP Nervous Glioblastoma A172 N/A
Location Method Result Regulation Validation Type Source
chr1:15492362-15492384 Luciferase Reporter Assay POSITIVE DIRECT TarBase 8.0
Floyd DH. et al. 2014 RP Nervous Glioblastoma U373 N/A
Location Method Result Regulation Validation Type Source
chr1:15492362-15492384 Luciferase Reporter Assay POSITIVE DIRECT TarBase 8.0
MCL1 hsa-miR-582-5p low: 1 high: 4 3 3 3 0.827
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Lam LT et al. 2010 RP Intestine HCT116 HCT116 N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Luciferase Reporter Assay POSITIVE DIRECT TarBase 8.0
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr1:150576920-150576946 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:150576493-150576512 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr1:150577291-150577319 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:150574680-150574702 HITS-CLIP POSITIVE DIRECT TarBase 7.0
IPO7 hsa-miR-582-5p low: 0 high: 5 2 2 2 0.969
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr11:9446959-9446982 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr11:9446678-9446706 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr11:9446678-9446706 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr11:9446678-9446706 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr11:9446678-9446706 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PLS3 hsa-miR-582-5p low: 0 high: 5 2 2 2 -
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chrX:115650293-115650301 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chrX:115650293-115650301 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chrX:115650293-115650301 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chrX:115650293-115650301 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chrX:115650293-115650301 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ITGA2 hsa-miR-582-5p low: 0 high: 5 1 1 1 0.932
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr5:53094555-53094563 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr5:53094555-53094563 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr5:53094555-53094563 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr5:53094555-53094563 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr5:53094555-53094563 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RTN4 hsa-miR-582-5p low: 0 high: 4 4 4 4 -
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr2:54972223-54972248 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr2:54972223-54972248 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr2:54972223-54972248 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:54972223-54972248 HITS-CLIP POSITIVE DIRECT TarBase 7.0
GREB1L hsa-miR-582-5p low: 0 high: 4 3 3 3 -
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr18:21525250-21525275 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr18:21525250-21525275 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr18:21505837-21505859 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr18:21525250-21525275 PAR-CLIP POSITIVE DIRECT TarBase 7.0
DICER1 hsa-miR-582-5p low: 0 high: 4 3 3 3 -
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr14:95089041-95089048 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr14:95086465-95086492 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr14:95086465-95086492 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr14:95089041-95089048 PAR-CLIP POSITIVE DIRECT TarBase 7.0
ZNF800 hsa-miR-582-5p low: 0 high: 3 3 3 3 0.891
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr7:127370450-127370476 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr7:127373870-127373896 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr7:127370450-127370476 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ADNP hsa-miR-582-5p low: 0 high: 3 3 3 3 0.647
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr20:50893615-50893625 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr20:50903939-50903960 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr20:50893615-50893625 PAR-CLIP POSITIVE DIRECT TarBase 7.0
GLCCI1 hsa-miR-582-5p low: 0 high: 3 3 3 3 0.653
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr7:8086944-8086968 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr7:8086889-8086917 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr7:8086258-8086284 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NUFIP2 hsa-miR-582-5p low: 0 high: 3 3 3 3 0.853
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr17:29257628-29257651 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:29263631-29263649 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:29263631-29263649 PAR-CLIP POSITIVE DIRECT TarBase 7.0
PUM1 hsa-miR-582-5p low: 0 high: 3 3 3 3 0.627
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr1:30932093-30932119 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr1:30931776-30931787 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:30932093-30932119 HITS-CLIP POSITIVE DIRECT TarBase 7.0
POU2F1 hsa-miR-582-5p low: 0 high: 3 3 3 3 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:167427272-167427284 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr1:167421259-167421286 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:167427272-167427284 PAR-CLIP POSITIVE DIRECT TarBase 7.0
AP1G1 hsa-miR-582-5p low: 0 high: 3 3 3 3 0.926
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr16:71729244-71729251 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr16:71729244-71729251 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr16:71729244-71729251 PAR-CLIP POSITIVE DIRECT TarBase 7.0
TRIAP1 hsa-miR-582-5p low: 0 high: 3 3 3 3 0.555
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr12:120444013-120444032 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:120443980-120444008 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:120444013-120444032 PAR-CLIP POSITIVE DIRECT TarBase 7.0
ZNF217 hsa-miR-582-5p low: 0 high: 3 3 3 3 0.579
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr20:53568876-53568892 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr20:53568876-53568892 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr20:53568876-53568892 PAR-CLIP POSITIVE DIRECT TarBase 7.0
MARCKSL1 hsa-miR-582-5p low: 0 high: 3 3 3 3 0.863
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr1:32334000-32334020 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:32334000-32334020 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:32333871-32333889 HITS-CLIP POSITIVE DIRECT TarBase 7.0